ThomasJ.DoyleMD

Oncology • Troy, MI

Physician

Join to view full profile

Dr. Doyle is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Doyle's full profile

Already have an account?

Office
2825 Livernois Rd
Troy, MI 48083
Phone+1 313-916-2600

Fax+1 313-916-3235
Is this information wrong?

Education & Training

Henry Ford HospitalFellowship, Hematology and Medical Oncology, 1979 - 1981
Henry Ford HospitalResidency, Internal Medicine, 1976 - 1979
Michigan State University College of Human MedicineClass of 1976

Certifications & Licensure

MI State Medical License 1978 - 2019

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Top MD Consumers Checkbook

Clinical Trials

Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Start of enrollment: 2005 Mar 01
Completed
Not Applicable
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib Start of enrollment: 2013 Jun 28
Completed
Phase 3
Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2013 Oct 14
Completed
Phase 2
NSABP Biospecimen Discovery Project Start of enrollment: 2013 Jul 01
Active, not recruiting
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery Start of enrollment: 2013 Aug 01
Active, not recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

6 citations
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma
Jessica Fleming, Stephanie L. Pugh, Barbara Fisher, Glenn J. Lesser, David R. Macdonald, Erica Hlavin Bell, Joseph P. McElroy, Aline Paixão Becker, Cynthia D Timmers, ...> ;JCO Precision Oncology. 2021 Sep 1
8 citations
Utilization of the 21-Gene Recurrence Score in a Diverse Breast Cancer Patient Population: Development of a Clinicopathologic Model to Predict High-Risk Scores and Res...
Ko-Un Park, Yalei Chen, Dhananjay Chitale, Sarah Choi, Haythem Ali, S. David Nathanson, Jessica Bensenhaver, Erica Proctor, Lindsay Petersen, Randa Loutfi, Alyson Simo...> ;Annals of Surgical Oncology. 2018 Apr 20

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Henry Ford HospitalDetroit, Michigan
Henry Ford West Bloomfield HospitalWest Bloomfield, Michigan